video
Urofollitropin FSH For Injection

Urofollitropin FSH For Injection

Urofollitropin is a critical component in fertility treatments, helping many individuals and couples achieve pregnancy when other methods have not been successful.

Product Introduction
Product Introduction

 

CAS Number: 97048-13-0

Standard: In-house

Urofollitropin is a critical component in fertility treatments, helping many individuals and couples achieve pregnancy when other methods have not been successful.

 

Applications

 

Urofollitropin is a highly purified form of follicle-stimulating hormone (FSH), which plays a critical role in fertility treatments. FSH is a gonadotropin, a type of hormone that is essential for the development of eggs in the ovaries of women and sperm in the testes of men. Urofollitropin is derived from the urine of postmenopausal women, who naturally have higher levels of this hormone due to the cessation of their reproductive cycles. This hormone is primarily used to stimulate the ovaries in women undergoing assisted reproductive technologies, such as in vitro fertilization (IVF).

 

Urofollitropin is typically administered via subcutaneous (under the skin) or intramuscular (into the muscle) injection. The dosages and duration of treatment are tailored to each individual based on their response to the medication and the specific treatment protocol being used.

 

This medication is used in women with ovulation disorders, those who do not produce enough endogenous FSH, or those undergoing controlled ovarian hyperstimulation for assisted reproductive technologies. It helps in cases where natural ovulation is not occurring or is insufficient for achieving pregnancy.

 

Common side effects of urofollitropin include abdominal discomfort, bloating, headache, and injection site reactions such as redness or swelling. A serious but rare side effect is ovarian hyperstimulation syndrome (OHSS), which can cause severe abdominal pain, nausea, vomiting, and rapid weight gain. OHSS requires immediate medical attention.

 

Patients receiving urofollitropin are closely monitored through blood tests and ultrasound to assess follicle development and minimize the risk of OHSS. This careful monitoring helps ensure that the ovaries are responding appropriately to the treatment and reduces the risk of complications.

 

Urofollitropin is a critical component in fertility treatments, enabling many individuals and couples to achieve pregnancy when other methods have not been successful. Its role in stimulating the ovaries to produce multiple eggs is vital for the success of procedures like IVF, providing hope and opportunities for those facing fertility challenges.

Hot Tags: urofollitropin fsh for injection, China urofollitropin fsh for injection manufacturers, suppliers, factory, Thymosin Alpha 1, 79561-22-1, Urokinase, Oxitocina Humana, Maropitant Citrate, Atosiban Acetate

Send Inquiry

whatsapp

Phone

E-mail

Inquiry

Bag